Literature DB >> 11867076

The serum level of free testosterone is reduced in amyotrophic lateral sclerosis.

Alessandra Militello1, Gaetano Vitello, Christian Lunetta, Antonio Toscano, Gianni Maiorana, Tommaso Piccoli, Vincenzo La Bella.   

Abstract

Sporadic amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting upper and lower motoneurons. There is an approximately 2:1 higher incidence of ALS in men compared to women, and this has raised the hypothesis of an involvement of sex hormones in the etiopathogenesis of the disorder. In this work, the serum levels of dehydroepiandrosterone sulphate (DHEAS), 17-betaestradiol, free and total testosterone were measured in 35 patients with defined or probable ALS, according to the El-Escorial/WFN revisited criteria, and compared to those obtained from 57 disease controls, matched for age and gender to the ALS group. We found no differences between ALS cases and disease controls in the serum levels of DHEAS, 17-betaestradiol and total testosterone. Conversely, free testosterone was significantly decreased in the ALS group. Given that testosterone crosses the blood-brain barrier only as unbound form, we suggest a possible involvement of this sex hormone in the pathophysiology of this severe motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867076     DOI: 10.1016/s0022-510x(01)00688-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.

Authors:  Antonio Hayes-Punzo; Patrick Mulcrone; Michael Meyer; Jacalyn McHugh; Clive N Svendsen; Masatoshi Suzuki
Journal:  Amyotroph Lateral Scler       Date:  2012-03-13

Review 2.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Authors:  Emily R Rosario; Lilly Chang; Elizabeth H Head; Frank Z Stanczyk; Christian J Pike
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

Review 4.  Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.

Authors:  Nimra Hasnain; Taha Bin Arif; Roha Shafaut; Faiza Zakaria; Syeda Zainab Fatima; Ibtehaj Ul Haque
Journal:  Wien Med Wochenschr       Date:  2022-06-20

Review 5.  Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord.

Authors:  L Zubeldia-Brenner; C E Roselli; S E Recabarren; M C Gonzalez Deniselle; H E Lara
Journal:  J Neuroendocrinol       Date:  2016-07       Impact factor: 3.627

Review 6.  Androgen cell signaling pathways involved in neuroprotective actions.

Authors:  Christian J Pike; Thuy-Vi V Nguyen; Martin Ramsden; Mingzhong Yao; M Paul Murphy; Emily R Rosario
Journal:  Horm Behav       Date:  2007-11-22       Impact factor: 3.587

7.  Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.

Authors:  Young-Eun Yoo; Chien-Ping Ko
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

8.  FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.

Authors:  Atsushi Yamaguchi; Keisuke Takanashi
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

Review 9.  The effects of diet and sex in amyotrophic lateral sclerosis.

Authors:  J A Pape; J H Grose
Journal:  Rev Neurol (Paris)       Date:  2020-03-05       Impact factor: 2.607

10.  Dihydrotestosterone in Amyotrophic lateral sclerosis-The missing link?

Authors:  Nishit Sawal; Jasbinder Kaur; Kamaljeet Kaur; Satinder Gombar
Journal:  Brain Behav       Date:  2020-10-13       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.